SCHEMBL9675356

SCHEMBL9675356

CC(=O)C(O)(c1ccccc1)C1CCC1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.69
NFE2L2 Q16236 1/20 0.69
CHRM3 P20309 11/20 0.56
CHRM2 P08172 6/20 0.52
CHRM1 P11229 5/20 0.52
ALDH1A1 P00352 2/20 0.52
KCNH2 Q12809 2/20 0.50
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50
HRH1 P35367 1/20 0.50
HTR2B P41595 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
SLC6A3 Q01959 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889937 0.96 KEAP1 (0.74) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL3051018 0.95 KEAP1 (0.72) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL9809511 0.95 KEAP1 (0.72) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL23581780 0.93 KEAP1 (0.70) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL29996978 0.90 KEAP1 (0.81) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL6590164 0.85 KEAP1 (0.93) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL2763565 0.85 KEAP1 (0.93) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL3913217 0.85 KEAP1 (0.93) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL27515279 0.82 KEAP1 (0.69) KEAP1NFE2L2CHRM3CHRM2CHRM1
SCHEMBL2062949 0.81 KEAP1 (1.00) KEAP1NFE2L2CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486734-A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders MARION MERRELL DOW INC. (US) 1992-05-27 EP disclosed
US-5001160-A 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders MARION LABORATORIES, INC. (US) 1991-03-19 US disclosed